Log in or Sign up for Free to view tailored content for your specialty!
Schizophrenia News
VIDEO: Case-based collaborative learning useful in psychoeducation
NEW YORK — In this Healio Video Perspective, Hyun Jung Kim, MD, discusses the format of her presentation on the relationship between cannabis use and risk for psychosis at the American Psychiatric Association Annual Meeting.
Patients with sarcoma, mental health disorders may have poor outcomes
Published results showed patients with a mental health diagnosis who undergo surgery for bone or soft tissue sarcoma may be at risk for longer hospital stays, readmission and surgical site infection.
Brain stimulation may have distinct near-maximal effective doses across mental disorders
Significant dose-response associations were found for transcranial magnetic stimulation and transcranial direct current stimulation across several mental disorders, including schizophrenia and depression, according to research.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Co-occurring schizophrenia, stimulant use disorder ‘challenging’ to treat
NEW YORK — The prevalence of substance use disorders is high among patients with schizophrenia, Randall F. White, MD, said in this Healio Video Perspective from the American Psychiatric Association Annual Meeting.
Psychosis may be linked to ovarian dysfunction conditions in adolescent females
NEW YORK — Gynecological conditions with hormonal derangements may contribute to secondary psychosis among adolescent females, according to results of a literature review presented at the American Psychiatric Association Annual Meeting.
VIDEO: May is Mental Health Awareness Month
NEW YORK — May is Mental Health Awareness Month, a perfect opportunity for individuals to focus on their state of mind, Carol A. Bernstein, MD, said in this Healio video from the American Psychiatric Association annual meeting.
Evenamide meets primary endpoint in phase 2/3 study of patients with schizophrenia
Newron Pharmaceuticals announced positive topline results from its phase 2/3 study of evenamide for patients with chronic schizophrenia who have an inadequate response to current treatment with a second-generation antipsychotic.
Positive efficacy results reported in phase 3 study of schizophrenia injectable
Teva Pharmaceuticals and Medincell have announced positive efficacy results from the phase 3 SOLARIS clinical trial evaluating an investigational, monthly subcutaneous injectable in adults with schizophrenia.
Lithium in drinking water linked to negative effects on human health
NEW YORK — Lithium exposure in drinking water was associated with potentially detrimental effects on human health, including increased risk for autism spectrum disorder and schizophrenia spectrum disorder, according to researchers.
Q&A: Keto diet may improve symptoms of severe mental illness
Results of a small pilot study suggest that the ketogenic diet may help counter adverse metabolic effects of psychotropic medications and improve mental health among adults with schizophrenia or bipolar disorder.
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read